Apogee Therapeutics, Inc.
(NASDAQ: APGE)
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.
75.610
+0.110
(+0.15%)
Range
74.700 - 75.712
(1.35%)
Open
74.880
Previous Close
75.500
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
47,199
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 23:07.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
